Skip to content

TruSpine Technolgs. - Shareholder Requisition Notice


Announcement provided by

TruSpine Technologies Plc · TSP

26/04/2023 10:35

TruSpine Technolgs. - Shareholder Requisition Notice
RNS Number : 5447X
TruSpine Technologies PLC
26 April 2023
 

 

 

26 April 2023

TruSpine Technologies plc

("TruSpine" or the "Company")

 

Shareholder Requisition Notice

 

 

TruSpine Technologies Plc, the medical device company focused on the spinal (vertebral) stabilisation market, announces that it has received an email dated 14 April 2023 from Janice Stone, Peter Houghton, Todd Michael Cramer and Christopher Blank (together the "Named Shareholders"), who hold in excess of 5 per cent. of the issued share capital of the Company, requiring that the Company convene, as soon as reasonably practicable, a general meeting ("Requisition").

 

The board changes proposed by the Named Shareholders are:

 

i.      that Norman Lott be removed as a director and company secretary of the Company;

ii.     that Nikunj Patel be removed as a director of the Company;

iii.    that Annabel Schild be removed as a director of the Company;

iv.   that Laurence Strauss be removed as a director of the Company;

v.    that Todd Michael Cramer be appointed as a director of the Company;

vi.   that Peter Houghton be appointed as a director of the Company;

vii.  that Anthony Swoboda be appointed a director of the Company; and

viii. that the adjourned 2022 annual general meeting be re-convened as soon as reasonably practical.

 

The letter is a requisition by the Named Shareholders under section 303 of the Companies Act 2006.

 

The Company is mindful that, pursuant to section 304 of the Companies Act 2006, the Company must post a notice convening a general meeting within 21 days from the date on which the requisition was received, and this meeting must be held on a date not more than 28 days after the date of the notice to shareholders convening the general meeting.

 

A further announcement will be made regarding a general meeting in due course.

 

This announcement contains inside information for the purposes of the UK Market Abuse Regulation, and the Directors of the Company are responsible for the release of this announcement.

Enquiries:

TruSpine Technologies Plc

Tel: +44 (0)20 3638 5025

Laurence Strauss, Chief Executive Officer




Cairn Financial Advisers LLP (AQSE Corporate Adviser)

Tel: +44 (0)20 7213 0880

Liam Murray / Ludovico Lazzaretti


Oberon Capital (Joint Broker)

 
Tel: +44 (0)20 3179 5300

Mike Seabrook / Chris Crawford

 


Peterhouse Capital Limited (Joint Broker & Financial Adviser)

 
Tel: +44 (0)20 7469 0930

Lucy Williams / Duncan Vasey

 


Novus Communications (PR and IR)

Tel: +44 (0)207 448 9839

Alan Green / Jacqueline Briscoe

novuscomms@truspine.org

Caution regarding forward looking statements

Certain statements in this announcement, are, or may be deemed to be, forward looking statements. Forward looking statements are identified by their use of terms and phrases such as ''believe'', ''could'', "should" ''envisage'', ''estimate'', ''intend'', ''may'', ''plan'', ''potentially'', "expect", ''will'' or the negative of those, variations or comparable expressions, including references to assumptions. These forward-looking statements are not based on historical facts but rather on the Directors' current expectations and assumptions regarding the Company's future growth, results of operations, performance, future capital and other expenditures (including the amount, nature and sources of funding thereof), competitive advantages, business prospects and opportunities. Such forward looking statements reflect the Directors' current beliefs and assumptions and are based on information currently available to the Directors.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NEXIFMLTMTJTMTJ ]]>

View more ...

TSP announcementsAll announcements

Company

  • About
  • News
  • Investor Relations
  • Contact
  • Careers

© Aquis Exchange 2024. All rights reserved.

Terms & ConditionsPrivacy PolicyModern Slavery & Human Trafficking Policy
System statusnormal